Internal Medicine, Infectious Disease · Hillsborough, NJ
NPI
1023084928
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
105 Raider Blvd, Suite 101
Hillsborough, NJ, 08844
Phone (908) 281-0221
Groups this clinician bills Medicare through
Medicare paid, 2024
$224K
22,795 services
Medicare patients, 2024
167
Average age 73
Drug cost, 2024
$2.7M
1,589 prescriptions
Company payments, 2025
$5,176
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald G Nahass was code 99213 (office e&m - established), 121 times for 73 patients. In total Ronald G Nahass billed 22,795 services in 53 codes, and Medicare paid $224K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 121 | 73 | $75.18 | $9,097 |
| 99214 Office E&M - Established | Office | 112 | 63 | $102.48 | $11K |
| 96372 Injection Administration | Office | 74 | 13 | $11.83 | $875 |
| 96365 Intravenous Infusion, Hydration | Office | 65 | 17 | $55.22 | $3,589 |
| 36410 Vascular | Office | 61 | 16 | $15.69 | $957 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 53 | 29 | $13.79 | $731 |
| 99204 Office E&M - New | Office | 12 | 12 | $145.74 | $1,749 |
| 90673 Vaccine Product | Office | 11 | 11 | $81.82 | $900 |
By year: 2022 $307K for 83,655 services; 2023 $238K for 42,699 services; 2024 $224K for 22,795 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 12 | $8.40 | $143 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald G Nahass prescribed most often to Medicare patients was Dovato (Dolutegravir Sodium/Lamivudine), with 103 prescriptions and refills. In total Ronald G Nahass wrote 1,589 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dovato Dolutegravir Sodium/Lamivudine | 103 | 109 | 14 | $344K |
| Valacyclovir Valacyclovir Hcl | 67 | 164 | 18 | $3,590 |
| Descovy Emtricitabine/Tenofov Alafenam | 55 | 63 | Under 11 | $139K |
| Rosuvastatin Calcium Generic | 52 | 129 | 15 | $802 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 51 | 51 | Under 11 | $212K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 49 | 49 | Under 11 | $185K |
| Juluca Dolutegravir/Rilpivirine | 44 | 44 | Under 11 | $152K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 44 | 44 | Under 11 | $175K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 40 | 40 | Under 11 | $157K |
| Cefadroxil Generic | 34 | 68 | Under 11 | $3,239 |
| Atorvastatin Calcium Generic | 34 | 100 | Under 11 | $315 |
| Ozempic Semaglutide | 33 | 52 | Under 11 | $51K |
| Valsartan Generic | 33 | 81 | Under 11 | $891 |
| Prezcobix Darunavir/Cobicistat | 26 | 26 | Under 11 | $64K |
| Tivicay Dolutegravir Sodium | 26 | 26 | Under 11 | $90K |
Brand drugs: 756 claims; generic drugs: 809 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald G Nahass $5,176 ($5,176 in general payments such as food, travel and fees) from 20 companies. The largest payer was Integra LifeSciences Corporation with $3,220.
| Company | Payments | Amount |
|---|---|---|
| Integra LifeSciences Corporation IART | 3 | $3,220 |
| Gilead Sciences, Inc. GILD | 18 | $444 |
| ViiV Healthcare Company GSK | 28 | $390 |
| Abbvie Inc. ABBV | 9 | $248 |
| Aimmune Therapeutics, Inc. | 7 | $231 |
| Shionogi Inc 4507.T | 2 | $136 |
| Merck Sharp & Dohme LLC MRK | 7 | $117 |
| Insmed, Inc. INSM | 6 | $98.62 |
| Paratek Pharmaceuticals, Inc. | 4 | $66 |
| Pfizer Inc. PFE | 3 | $46.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.